In both cases, by analysing 'end-stage' cancer cells, these investigations will have focused on the antiapoptotic effects of NF-κB, which we also see, but will have missed any more complex roles that might occur during the process of lymphomagenesis itself. The gene discussed is NFKB1; the disease is cancer.